Search results
7 Myths About Kidney Cancer, Debunked
Time via Yahoo News· 1 year agodoctor holding orange ribbon. campaign to prevent skin cancer, melanoma, December orange Credit - Leonidas Santana—Getty Images Kidney cancer may well be...
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
Zacks via Yahoo Finance· 5 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
Zacks via Yahoo Finance· 5 months agoExelixis, Inc. EXEL entered into a clinical collaboration with clinical-stage company Arcus...
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 2 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...
New hope for kidney cancer treatment using existing drugs
Press Association News via AOL· 1 year agoResearchers say a new study of kidney cancer offers hope for treating the disease using existing...
Girl, 17, diagnosed with stage 4 cancer after doctors said her back pain was a pulled muscle
TODAY via Yahoo News· 3 months agoIn late 2022, Shimia Nord experienced such intense back pain that she failed her driver’s test....
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...
Kidney Removal: Pre- and Post-Op Guidance
Verywell Health via Yahoo News· 4 months agoTypes of Nephrectomy and What to Expect Medically reviewed by David Hampton, MD Kidney removal, or nephrectomy, is a type of surgery that removes part of...
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
Zacks via Yahoo Finance· 2 months agoThings are looking better for the biotech industry in 2024 after a decent performance in 2023. The...
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...